Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Joby Aviation Inc (NYSE:JOBY) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 ...

This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Q2 2025 Management View Paul Richards, EVP and CFO, reported "For the second quarter, we reported a net income of $0.54 per ...

Arcutis Biotherapeutics Inc (NASDAQ:ARQT) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for ...

Medifast, Inc. (MED) delivered second-quarter 2025 results, wherein both the top and bottom lines beat the Zacks Consensus ...

The best place to start is to determine how the stock is valued, and one of the most popular and effective metrics to help make that judgment is earnings per share, known as EPS. "We use a wide ...

Palantir recently secured a major victory with the U.S. Army's new Enterprise Agreement that establishes a comprehensive ...

Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.

Earnings can cause stock prices to rise, and when they do, investors make money. If a company has high earnings per share, it means it has more money available to either reinvest in the business ...